Moreover, in this latter study, no significant differences were observed in rate of leukemic transformation or in survival outcomes between CMML patients with or without NPM1 mutations, probably due to the limited number of patients analyzed [80]. The gene discussed is NPM1; the disease is chronic myelomonocytic leukemia.